Chemicals News and Research

RSS

Light activated treatments could solve MRSA problems after surgery

Killer dyes that can wipe out bacteria could help solve the superbug problems faced by surgical patients, scientists heard today (Wednesday 10 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.

9 Sep 2008

Prenatal exposure to pollution a culprit in obesity

According to new research a determining factor as to whether a child is fat or not may be decided before they have even been born.

8 Sep 2008

Rattlesnake-type poisons used by superbug bacteria to beat our defences

Colonies of hospital superbugs can make poisons similar to those found in rattlesnake venom to attack our bodies' natural defences, scientists heard today (Monday 8 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.

7 Sep 2008

Georgia Institute of Technology receives EPA safe drinking water research grant

The U.S. Environmental Protection Agency announced the award of a $600,000 research grant to Georgia Tech to improve the detection of known and emerging drinking water contaminants; including the harmful substances produced by blue-green algae in algal blooms and noroviruses.

4 Sep 2008

National Toxicology Program finalizes report on Bisphenol A

Current human exposure to bisphenol A (BPA), a chemical used in many polycarbonate plastics and epoxy resins, is of "some concern" for effects on development of the prostate gland and brain and for behavioral effects in fetuses, infants and children, according to a final report released today by the National Toxicology Program (NTP).

3 Sep 2008

Uganda's Health Ministry orders $1.8 million worth of antiretrovirals to address drug shortage

Uganda's Ministry of Health is expecting a batch of antiretroviral drugs to "arrive any time," Sam Zaramba, director-general of health services, announced on Tuesday following a drug shortage confirmed by health officials in the country last week, the New Vision/AllAfrica.com reports.

1 Sep 2008

Pregnant women warned off using perfumed products

Pregnant women have been warned not to use scented creams or perfumes during the first three months of their pregnancy because they may jeopardise the future fertility of unborn boys.

1 Sep 2008

New role for Natural Killer cells

Scientists at the University of York have discovered a new role for a population of white blood cells, which may lead to improved treatments for chronic infections and cancer.

28 Aug 2008

New kind of bioglass to help bones mend

Scientists at the Nuclear-Magnetic Resonance unit at the University of Warwick have discovered how a high tech glass of milk is helping bones mend.

26 Aug 2008

Century old rule of chemistry overturned - major implications for drug delivery

A new study by research chemists at the University of Warwick has challenged a century old rule of pharmacology that defined how quickly key chemicals can pass across cell walls. The new observations of the Warwick researchers suggest that the real transport rates could be up to a hundred times slower than predicted by the century old "Overton's Rule". This could have major implications for the development and testing of many future drugs.

25 Aug 2008

Mosquitoes stay away from DEET because they hate the smell!

According to scientists in the U.S. the reason why the insect repellent DEET works so well is because mosquitoes don't like the smell.

25 Aug 2008

U.S. spinach and lettuce to be irradiated to stop outbreaks of foodborne bacteria

Following an increasing number of outbreaks of foodborne illnesses over the last few years, the Food and Drug Administration (FDA) in the United States is about to allow food producers to irradiate spinach and iceberg lettuce to kill foodborne bacteria.

25 Aug 2008

Researchers discover key details of how rheumatoid arthritis destroys bone

Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. The findings are already guiding attempts to design new drugs to reverse RA-related bone loss and may also address more common forms of osteoporosis with a few adjustments.

24 Aug 2008

Skin odors used to detect basal cell carcinoma

According to new research from the Monell Center, odors from skin can be used to identify basal cell carcinoma, the most common form of skin cancer. The findings, presented at the 236th meeting of the American Chemical Society, may open doors to development of new methods to detect basal cell carcinoma and other forms of skin cancer.

20 Aug 2008

New discovery on how rheumatoid arthritis destroys bone

20 Aug 2008

Scientists synthesize promising anti-cancer product from marine algae

Duke University chemists have patented an efficient technique for synthesizing a marine algae extract in sufficient quantities to now test its ability to inhibit the growth of cancerous cells while leaving normal cells unaffected.

20 Aug 2008

New discovery may lead to new drugs to regulate sleep

A team of scientists from Oxford University in the UK have discovered the reason why people feel drowsier in dim lighting and more alert in bright white light.

19 Aug 2008

Researchers create synthetic heparin

Robert Linhardt has spent years stitching together minuscule carbohydrates to build a more pure and safer alternative to the commonly used and controversial blood thinner heparin. At the national conference of the American Chemical Society on August 17, 2008, Linhardt announced that his research team may have accomplished this task by building the first fully synthetic heparin. Their creation is the largest dose of heparin ever created in the lab.

17 Aug 2008

President signs bill that bans six toxic phthalates from children's products

President Bush signed a federal bill today that bans six toxic phthalates from children's products. His signature bolsters Congress' overwhelming support for this legislation, and sends a clear message that toxic chemicals have no place in toys.

14 Aug 2008

Diakron licenses anticoagulant drug candidate from Merck

Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co. Inc. Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide.

13 Aug 2008